FFCD - Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302)

Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302)

Auteurs

Alexandra Lapeyre-Prost, Simon Pernot, Julie Sigrand, Karine Le Malicot, Florence Mary, Thomas Aparicio, Laetitia Dahan, François-Xavier Caroli-Bosc, Thierry Lecomte, Solène Doat, Lysianne Marthey, Jérôme Desrame, Come Lepage, Julien Taieb

Journal / Conférence

Clinical Colorectal Cancer

Type de publication

Article

Etude

PRODIGE 45 HIGHLIGHT

Localisation

Colorectal